Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - OPERATING EXPENSES
Operating Expenses KROS - Keros Therapeutics, Inc.
170 M
LAST VALUE
49.14%
2 YEAR CAGR
71.93%
5 YEAR CAGR
0.00%
10 YEAR CAGR